SOBOL PHILIP A 5
5 · Entia Biosciences, Inc. · Filed Jan 22, 2013
Insider Transaction Report
Form 5
SOBOL PHILIP A
Director
Transactions
- Award
Series A Preferrred Stock
2012-11-20$5.00/sh+3,000$15,000→ 8,000 total(indirect: By Trust)Exercise: $0.50From: 2013-11-20→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The conversion price is adjustable pursuant to certain anti-dilution provisions.
- [F2]The preferred shares are convertible into common shares at any time, but under certain circumstances there could be a mandatory conversion, as for example after the annivesary of the effectiveness of a registration statement covering the common stock underlying the preferred shares or within 30 days of the closing of a private placement exceeding $5 million.